Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 978.00
Bid: 980.00
Ask: 984.00
Change: -6.00 (-0.61%)
Spread: 4.00 (0.408%)
Open: 971.00
High: 997.00
Low: 971.00
Prev. Close: 984.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to CMA review into veterinary market

7 Sep 2023 10:50

RNS Number : 7397L
CVS Group plc
07 September 2023
 

7 September 2023

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

 

Response to CMA review into the veterinary services market

 

CVS, the UK quoted veterinary group and a leading provider of integrated veterinary services, notes that the Competition and Markets Authority ("CMA") has launched a review into the UK veterinary services market for household pets. We always work closely with our regulators and we and our colleagues will support the CMA review.

 

Our purpose at CVS is to give the best possible care to animals and we continually invest in our colleagues, practices and clinical equipment to enhance the care to our clients and their patients. The Group has always sought to ensure its prices are appropriate and reflect fair value to our clients. Our pricing structures are set by clinicians to ensure these align with our purpose.

 

As the CMA have recognised, there continues to be a significant shortage of vets in the UK and employment costs represent the most significant proportion of our cost base. Our pricing reflects this and other inflationary pressures experienced in recent years.

 

We have a clear strategy to continue to expand our network and to improve clinical care through investment in facilities, equipment, technology and our people.

 

We will announce our full year results on 21 September 2023.

 

 

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, Deputy CEO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR) cvsg@camarco.co.uk

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Rosie Driscoll +44 (0)7752 245 008

 

 

 

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in Australia, the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including nine specialist referral hospitals and 39 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,700 personnel, including c.2,250 veterinary surgeons and c.3,200 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPURCBUPWUBM
Date   Source Headline
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options
15th Dec 202111:30 amRNSPDMR/PCA Dealings
13th Dec 20217:00 amRNSPDMR/PCA Dealings
7th Dec 202111:06 amRNSPDMR/PCA Dealings
30th Nov 20217:00 amRNSExercise of Options and Total Voting Rights
26th Nov 20215:31 pmRNSHolding(s) in Company
26th Nov 20215:24 pmRNSHolding(s) in Company
26th Nov 20218:16 amRNSGrant of Options & PDMR Dealing
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update
19th Nov 20214:26 pmRNSHolding(s) in Company
10th Nov 202111:17 amRNSHolding(s) in Company
3rd Nov 20212:30 pmRNSPCA Shareholding
1st Nov 20218:00 amRNSHolding(s) in Company
29th Oct 202110:17 amRNSPosting of Annual Report & Notice of AGM
29th Oct 20217:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20216:01 pmRNSExercise of Options, PDMR Dealing and TVR
7th Oct 20211:52 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSLong Term Incentive Plan Awards & PDMR Dealing
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
29th Sep 20215:28 pmRNSHolding(s) in Company
28th Sep 20217:54 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSBoard Changes
23rd Sep 20217:00 amRNSFinal results for the year ended 30 June 2021
13th Sep 20211:50 pmRNSHolding(s) in Company
31st Aug 20217:00 amRNSExercise of Options and Total Voting Rights
27th Aug 20215:34 pmRNSHolding(s) in Company
26th Aug 20218:48 amRNSBlock Listing Application
24th Aug 20214:10 pmRNSHolding(s) in Company
20th Aug 20212:09 pmRNSHolding(s) in Company
20th Aug 20212:07 pmRNSHolding(s) in Company
30th Jul 202112:00 pmRNSExercise of Options and Total Voting Rights
29th Jul 20214:14 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTrading Update
13th Jul 202112:40 pmRNSBlock Listing Interim Review and TVR Update
30th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
28th May 202112:00 pmRNSExercise of Options and Total Voting Rights
13th May 20218:30 amRNSShareholder Consultation regarding 2020 AGM
30th Apr 202112:00 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSTrading Update
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20219:06 amRNSDirector/PDMR and PCA Shareholding
25th Mar 20217:00 amRNSInterim Results
3rd Mar 20217:30 amRNSHolding(s) in Company
26th Feb 202112:00 pmRNSExercise of Options and Total Voting Rights
5th Feb 20214:30 pmRNSHolding(s) in Company
29th Jan 202112:00 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.